Skyhawk news

Browse:

Skyhawk's proprietary platform revolutionizes disease treatment by developing small molecule therapeutics that modify RNA expression

June 26, 2018
Skyhawk Announces Strategic Collaboration with Celgene to Discover and Develop Novel mRNA Splicing Modifiers using Skyhawk's STAR Technology Platform
Skyhawk and Celgene enter into a five-year strategic collaboration.
Read
2 min read
January 24, 2018
The new serial entrepreneur in the biotech arena launches another upstart looking to drug RNA
Af­ter a life­time of en­tre­pre­neur­ship, Bill Haney has dis­cov­ered how much fun it can be to set up new biotechs.
Read
3 min read
January 24, 2018
Skyhawk, copying Dragonfly model, gets cash for RNA R&D
Tim Disney—the great-nephew of Walt Disney—is among those who have signed term sheets.
Read
2 min read
January 2, 2018
Disney, Family Offices Back Second Bio Startup from Tech Entrepreneur Haney
To launch his first biotech startup, Dragonfly Therapeutics, Bill Haney went to private family offices, including one linked to the...
Read
4 min read
June 30, 2026
Skyhawk Therapeutics Releases Twelve-Month cUHDRS Subcomponent Results from its Phase 1/2 Clinical Trial of SKY-0515 in Huntington’s Disease
Twelve-month findings showed favorable and consistent trends for participants receiving SKY-0515 across all four cUHDRS subcomponents, including Total Functional Capacity (TFC), Total Motor Score (TMS), Symbol Digit Modalities Test (SDMT), and Stroop Word Reading Test (SWRT)
Read
6 min read